| Image |
|
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
|
| Diseases |
|
| GWAS |
- Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction) ( 28560309)
- Albumin-globulin ratio ( 29403010)
- Blood protein levels ( 29875488)
- Drug-induced liver injury (flucloxacillin) ( 19483685)
- Esophageal cancer (squamous cell) ( 22960999)
- IgA nephropathy ( 26028593)
- IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis) ( 28878392)
- IgG digalactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG disialylation phenotypes (multivariate analysis) ( 28878392)
- IgG fucosylation phenotypes (multivariate analysis) ( 28878392)
- IgG galactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG glycosylation ( 23382691)
- IgG monogalactosylation phenotypes (multivariate analysis) ( 28878392)
- IgG monosialylation phenotypes (multivariate analysis) ( 28878392)
- IgG N-glycosylation phenotypes (multivariate analysis) ( 28878392)
- IgG sialylation phenotypes (multivariate analysis) ( 28878392)
- N-glycan levels ( 31163085)
- Non-albumin protein levels ( 29403010)
- Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure) ( 21130132)
- Thyroglobulin plasma levels ( 30929638)
- Type 2 diabetes ( 30054458 21874001 30297969 30718926)
|
| Interacting Genes |
1 interacting genes:
CD22
|
| Entrez ID |
6480 |
| HPRD ID |
00184 |
| Ensembl ID |
ENSG00000073849
|
| Uniprot IDs |
P15907
|
| PDB IDs |
4JS1
4JS2
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|